Login / Signup

Can Zn Be a Critical Element in COVID-19 Treatment?

Mohammad Tariqur RahmanSyed Zahir Idid
Published in: Biological trace element research (2020)
The current COVID-19 pandemic caused by SARS-CoV-2 has prompted investigators worldwide to search for an effective anti-viral treatment. A number of anti-viral drugs such as ribavirin, remdesivir, lopinavir/ritonavir, antibiotics such as azithromycin and doxycycline, and anti-parasite such as ivermectin have been recommended for COVID-19 treatment. In addition, sufficient pre-clinical rationale and evidence have been presented to use chloroquine for the treatment of COVID-19. Furthermore, Zn has the ability to enhance innate and adaptive immunity in the course of a viral infection. Besides, Zn supplement can favour COVID-19 treatment using those suggested and/or recommended drugs. Again, the effectiveness of Zn can be enhanced by using chloroquine as an ionophore while Zn inside the infected cell can stop SARS-CoV-2 replication. Given those benefits, this perspective paper describes how and why Zn could be given due consideration as a complement to the prescribed treatment of COVID-19.
Keyphrases
  • sars cov
  • coronavirus disease
  • heavy metals
  • respiratory syndrome coronavirus
  • clinical trial
  • systematic review
  • immune response
  • stem cells
  • risk assessment
  • bone marrow